Telix Pharmaceuticals
TLX
8.37
-0.34
-3.90%
Telix Pharmaceuticals
US · TLX
#2345 by market cap
Listed 2024
8.37
-0.34
-3.90%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Quant vs Street three independent views, side by side
StockVane factor grade
C-
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 2 analysts
Buy
Avg price target 20.00 +138.9%
Price target rangecurrent 8.37
Low20.00
Avg20.00
High20.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (3)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-30 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-09-25 | H.C. Wainwright | -- | Buy | 20.00 |
| 2026-09-22 | William Blair | -- | Buy | -- |
Earnings history price reaction on the day
| Period | Report date | Session | Actual move |
|---|---|---|---|
| 2026/Q2 | 2026-08-19 | After close | +2.48% |
| 2025/Q4 | 2026-02-19 | After close | +14.61% |
| 2025/Q2 | 2025-08-20 | After close | +10.21% |
| 2024/Q4 | 2025-02-19 | After close | +1.28% |
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Telix Pharmaceuticals discussion 0 comments